Sign In
Buy OSUR
$4.00
-0.0500 (-1.23%)
At Close: Aug 10, 2026
OraSure (OSUR) Q2 Revenue Falls 43%
09:41pm, Tuesday, 05'th Aug 2025
OraSure (OSUR) Q2 Revenue Falls 43%
OraSure Technologies, Inc. (OSUR) Q2 2025 Earnings Call Transcript
08:17pm, Tuesday, 05'th Aug 2025
OraSure Technologies, Inc. (NASDAQ:OSUR ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Carrie Eglinton Manner - President, CEO & Director Jason Michael Plagman - Vic
OraSure Technologies (OSUR) Reports Q2 Loss, Beats Revenue Estimates
07:31pm, Tuesday, 05'th Aug 2025
OraSure Technologies (OSUR) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to earnings of $0.07 per share a year ago.
OraSure Appoints Anne Messing as Chief Commercial Officer
07:05am, Monday, 04'th Aug 2025
BETHLEHEM, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today anno
OraSure Technologies: An Asymmetric Bet
02:43am, Monday, 28'th Jul 2025
OraSure trades near cash value with minimal debt, reflecting excessive market pessimism and creating an asymmetric risk-reward opportunity. The company's future hinges on Sherlock's at-home STD test k
OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th
04:05pm, Monday, 21'st Jul 2025
BETHLEHEM, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2025 financial results and certai
OraSure Technologies received takeover bid from industry entrepreneur, sources say
12:03pm, Monday, 14'th Jul 2025
Prominent healthcare entrepreneur Ron Zwanziger approached medical device maker OraSure Technologies with a takeover offer, three people familiar with the matter said, in what would mark more consolid
OraSure Launches Novel Blood Collection Device for Proteomic Research
07:05am, Thursday, 10'th Jul 2025
The device has the potential to transform proteomic discovery through extended protein stabilization and a simplified workflow for research The device has the potential to transform proteomic discover
Orasure Technologies: Multiple Shots To Deliver Value
10:25am, Wednesday, 28'th May 2025
OSUR remains deeply undervalued, trading below liquidation value, with a robust, cash-rich, debt-free balance sheet providing downside protection. Key value drivers include a 20% share buyback, potent
OraSure Technologies, Inc. (OSUR) Q1 2025 Earnings Call Transcript
08:01pm, Wednesday, 07'th May 2025
OraSure Technologies, Inc. (NASDAQ:OSUR ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Jason Plagman - VP of Investor Relations Carrie Eglinton Manner - President & Chi
OraSure Technologies (OSUR) Reports Q1 Loss, Tops Revenue Estimates
07:01pm, Wednesday, 07'th May 2025
OraSure Technologies (OSUR) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to earnings of $0.04 per share a year ago.
OraSure Technologies: Historically Cheap
03:47pm, Wednesday, 30'th Apr 2025
OraSure Technologies shares have dipped below $3 since my last writing, making shares even cheaper. Recent developments at the company include the acquisition of Sherlock Biosciences and the announcem
OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th
04:05pm, Wednesday, 23'rd Apr 2025
BETHLEHEM, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2025 financial results and certai
OraSure Announces $40 Million Stock Repurchase Program
07:30am, Monday, 24'th Mar 2025
BETHLEHEM, Pa., March 24, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (the “Company”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, t
OraSure Technologies, Inc. (OSUR) Q4 2024 Earnings Call Transcript
05:49am, Thursday, 27'th Feb 2025
OraSure Technologies, Inc. (NASDAQ:OSUR ) Q4 2024 Results Conference Call February 25, 2025 5:00 PM ET Company Participants Jason Plagman - VP of Investor Relations Carrie Eglinton Manner - President
